National Guideline Clearinghouse | Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis.

full-text ►

National Guideline Clearinghouse | Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis.



National Institute for Health and Care Excellence (NICE)

Guideline Title

Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis.

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis. London (UK): National Institute for Health and Care Excellence (NICE); 2014 Mar. 69 p. (Technology appraisal guidance; no. 308).

Guideline Status

This is the current release of the guideline.